Form D · Biotechnology
HMDmd Inc.
Solana Beach, CA · CIK 0001907256
Offering snapshot reported Feb 7, 2022 · SEC filing
- Reported sold
- $2.07M Offering amount: $2.2M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 21, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2022 | Initial | $2,069,997 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $102K
- Finders' fees
- $0
- Form D file number
- 021-432607
Sales Commission includes an Engagement Fee of $15,000 and a Warrant to be issued to the the Recipients listed in Item 12 herein for the purchase of 79,090 shares of the Common Stock of the Issuer at a per share price of $1.10, for a value of $86,999.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Newbridge Securities Corporation | 104065 | |
| I-Bankers Direct, LLC | 167533 |
Source: Form D, filed Feb 7, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John R. Lyon | Director, Executive |
| Allen Newman | Director, Executive |
| Howard Sampson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
246 S. Highway 101, #339
Solana Beach, CA, 92075
Solana Beach, CA, 92075